Mainz Biomed B.V. (MYNZ)

Mainz Biomed B.V. (MYNZ) Financial Statements


Mainz Biomed B.V. Financial Overview

Mainz Biomed B.V.'s market cap is currently ―. The company's EPS TTM is $-1.861; its P/E ratio is -1.57; Mainz Biomed B.V. is scheduled to report earnings on November 1, 2023, and the estimated EPS forecast is $-0.47. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Jun 22Dec 21Jun 21Dec 20
Income Statement-
Total Revenue-----
Gross Profit-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 17.14M$ 26.01M$ 8.73M$ 195.16K$ 122.57K
Total Assets$ 20.24M$ 27.62M$ 10.04M$ 734.47K$ 673.27K
Total Debt$ 1.32M$ 2.49M$ 636.27K$ 675.88K$ 1.16M
Net Debt$ -15.82M$ -23.52M$ -8.09M$ 480.72K$ 1.04M
Total Liabilities$ 6.14M$ 3.84M$ 3.68M$ 3.15M$ 3.41M
Stockholders Equity$ -4.15M$ 23.77M$ 6.36M$ -2.41M$ -2.74M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

Mainz Biomed B.V. Earnings and Revenue History

Mainz Biomed B.V. Debt to Assets

Mainz Biomed B.V. Cash Flow

Mainz Biomed B.V. Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis